“…Mendes et al [174] reported on a single center experience of emergency ABO-I LT in 10 patients with severe hepatic failure, immediately leading to death without intervention. Plasmapheresis and IVIg were implemented for immune modulation before and after LT. At a mean follow-up of 19.6 mo post-LT, 5 of these [150] LT n = 1; post-LT, after detection of AMR Plasmapheresis, rituximab Intermittent decrease of Bili, liver enzymes and DSAs'; no survival Dar et al [151] SLKT n = 6; pre-and post-LT desensitization -Survival rate 83.3% Kozlowski et al [142] LT n = 3; post-LT, after detection of AMR Plasmapheresis, rituximab Transient decrease of Bili, yGT and DSAs' in 2 patients; survival rate 33.3% Koch et al [153] SLKT n = 1; post-LT, after liver function deterioration and detection of DSAs'…”